- Joined
- Nov 5, 2012
- Messages
- 125
- Reaction score
- 67
An interesting debate is ongoing between neurologists and neuroIRs at our hospital regarding the choice between unfractionated heparin vs. LMWH (lovenox) to best treat Cerebral venous thrombosis (CVT).
It would be interesting to hear your views. What do you prefer at your institutions?
Little more background story:
Several large and small prospective, meta analysis and small randomized studies showed superiority of Lovenox in terms of rate of hemorrhages and thrombus resolution. Thus, I proposed to use Lovenox. The neuroIR's view is that heparin is easier to reverse in case of bleed and intervention. My response to that is first, even if ICH occurs, anticoagulation should be continued in CVT rather than reversed since the bleed is due to venous pooling. Second, lovenox can be reversed w/ protamine as well. Lastly, IR intervention in CVT is not proven to be safe nor effective as of yet. AHS/ASA 2014 recommends either heparin or lovenox.
It would be interesting to hear your views. What do you prefer at your institutions?
Little more background story:
Several large and small prospective, meta analysis and small randomized studies showed superiority of Lovenox in terms of rate of hemorrhages and thrombus resolution. Thus, I proposed to use Lovenox. The neuroIR's view is that heparin is easier to reverse in case of bleed and intervention. My response to that is first, even if ICH occurs, anticoagulation should be continued in CVT rather than reversed since the bleed is due to venous pooling. Second, lovenox can be reversed w/ protamine as well. Lastly, IR intervention in CVT is not proven to be safe nor effective as of yet. AHS/ASA 2014 recommends either heparin or lovenox.
Last edited: